FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2902788100> ?p ?o ?g. }

• W2902788100 abstract "The newly registered adjuvanted herpes zoster subunit vaccine (HZ/su) has a higher efficacy than the available live-attenuated vaccine (ZVL). National decision-makers soon need to decide whether to introduce HZ/su or to prefer HZ/su above ZVL. Using a Markov model with a decision tree, we conducted a cost-effectiveness analysis of vaccination with HZ/su (two doses within 2 months) or zoster vaccine live (ZVL) (single dose, or single dose with a booster after 10 years) for cohorts of 50-, 60-, 70- or 80-year-olds in the Netherlands. The model was parameterized using vaccine efficacy data from randomized clinical trials and up-to-date incidence, costs and health-related quality of life data from national datasets. We used a time horizon of 15 years, and the analysis was conducted from the societal perspective. At a coverage of 50%, vaccination with two doses of HZ/su was estimated to prevent 4335 to 10,896 HZ cases, depending on the cohort age. In comparison, this reduction was estimated at 400–4877 for ZVL and 427–6466 for ZVL with a booster. The maximum vaccine cost per series of HZ/su to remain cost-effective to a willingness-to-pay threshold of €20,000 per quality-adjusted life year (QALY) gained ranged from €109.09 for 70-year-olds to €63.68 for 50-year-olds. The cost-effectiveness of ZVL changed considerably by age, with corresponding maximum vaccine cost per dose ranging from €51.37 for 60-year-olds to €0.73 for 80-year-olds. Adding a ZVL booster after 10 years would require a substantial reduction of the maximum cost per dose to remain cost-effective as compared to ZVL single dose. Sensitivity analyses on the vaccine cost demonstrated that there were scenarios in which vaccination with either HZ/su (two doses), ZVL single dose or ZVL + booster could be the most cost-effective strategy. A strategy with two doses of HZ/su was superior in reducing the burden of HZ as compared to a single dose or single dose + booster of ZVL. Both vaccines could potentially be cost-effective to a conventional Dutch willingness-to-pay threshold for preventive interventions. However, whether HZ/su or ZVL would be the most cost-effective alternative depends largely on the vaccine cost." @default.
• W2902788100 created "2018-12-11" @default.
• W2902788100 creator A5016565734 @default.
• W2902788100 creator A5017457298 @default.
• W2902788100 creator A5038643968 @default.
• W2902788100 creator A5047921978 @default.
• W2902788100 creator A5083963717 @default.
• W2902788100 creator A5085882145 @default.
• W2902788100 creator A5087209063 @default.
• W2902788100 date "2018-12-01" @default.
• W2902788100 modified "2023-10-08" @default.
• W2902788100 title "Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines" @default.
• W2902788100 cites W1496000468 @default.
• W2902788100 cites W1866145098 @default.
• W2902788100 cites W1985191422 @default.
• W2902788100 cites W1985668586 @default.
• W2902788100 cites W2008775818 @default.
• W2902788100 cites W2010207831 @default.
• W2902788100 cites W2011226248 @default.
• W2902788100 cites W2042582875 @default.
• W2902788100 cites W2045808882 @default.
• W2902788100 cites W2090377598 @default.
• W2902788100 cites W2125575192 @default.
• W2902788100 cites W2128911553 @default.
• W2902788100 cites W2131041950 @default.
• W2902788100 cites W2131244634 @default.
• W2902788100 cites W2146505189 @default.
• W2902788100 cites W2148882495 @default.
• W2902788100 cites W2149820050 @default.
• W2902788100 cites W2153996310 @default.
• W2902788100 cites W2154139509 @default.
• W2902788100 cites W2158191469 @default.
• W2902788100 cites W2168763662 @default.
• W2902788100 cites W2169817406 @default.
• W2902788100 cites W2173387046 @default.
• W2902788100 cites W2324892060 @default.
• W2902788100 cites W2329705186 @default.
• W2902788100 cites W2410220077 @default.
• W2902788100 cites W2507833965 @default.
• W2902788100 cites W2517417896 @default.
• W2902788100 cites W2519957152 @default.
• W2902788100 cites W2594715911 @default.
• W2902788100 cites W2605414763 @default.
• W2902788100 cites W2657185040 @default.
• W2902788100 cites W2733165904 @default.
• W2902788100 cites W2734597109 @default.
• W2902788100 cites W2734800292 @default.
• W2902788100 cites W2734980347 @default.
• W2902788100 cites W2746465596 @default.
• W2902788100 cites W2760564386 @default.
• W2902788100 cites W2769572231 @default.
• W2902788100 cites W2781747798 @default.
• W2902788100 cites W2784682748 @default.
• W2902788100 cites W2789983511 @default.
• W2902788100 cites W2825976670 @default.
• W2902788100 cites W2871208259 @default.
• W2902788100 cites W2883596402 @default.
• W2902788100 cites W2888131046 @default.
• W2902788100 cites W2810515195 @default.
• W2902788100 doi "https://doi.org/10.1186/s12916-018-1213-5" @default.
• W2902788100 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6282315" @default.
• W2902788100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30518427" @default.
• W2902788100 hasPublicationYear "2018" @default.
• W2902788100 type Work @default.
• W2902788100 sameAs 2902788100 @default.
• W2902788100 citedByCount "12" @default.
• W2902788100 countsByYear W29027881002018 @default.
• W2902788100 countsByYear W29027881002019 @default.
• W2902788100 countsByYear W29027881002021 @default.
• W2902788100 countsByYear W29027881002022 @default.
• W2902788100 countsByYear W29027881002023 @default.
• W2902788100 crossrefType "journal-article" @default.
• W2902788100 hasAuthorship W2902788100A5016565734 @default.
• W2902788100 hasAuthorship W2902788100A5017457298 @default.
• W2902788100 hasAuthorship W2902788100A5038643968 @default.
• W2902788100 hasAuthorship W2902788100A5047921978 @default.
• W2902788100 hasAuthorship W2902788100A5083963717 @default.
• W2902788100 hasAuthorship W2902788100A5085882145 @default.
• W2902788100 hasAuthorship W2902788100A5087209063 @default.
• W2902788100 hasBestOaLocation W29027881001 @default.
• W2902788100 hasConcept C112930515 @default.
• W2902788100 hasConcept C120665830 @default.
• W2902788100 hasConcept C121332964 @default.
• W2902788100 hasConcept C126322002 @default.
• W2902788100 hasConcept C168563851 @default.
• W2902788100 hasConcept C187212893 @default.
• W2902788100 hasConcept C203014093 @default.
• W2902788100 hasConcept C22070199 @default.
• W2902788100 hasConcept C2780441014 @default.
• W2902788100 hasConcept C3019080777 @default.
• W2902788100 hasConcept C515549039 @default.
• W2902788100 hasConcept C61511704 @default.
• W2902788100 hasConcept C64332521 @default.
• W2902788100 hasConcept C71924100 @default.
• W2902788100 hasConcept C72563966 @default.
• W2902788100 hasConceptScore W2902788100C112930515 @default.
• W2902788100 hasConceptScore W2902788100C120665830 @default.
• W2902788100 hasConceptScore W2902788100C121332964 @default.
• W2902788100 hasConceptScore W2902788100C126322002 @default.
• W2902788100 hasConceptScore W2902788100C168563851 @default.

• next